However, surprisingly, the concurrent findings of a JAK2 V617F mutation raised more challenging questions and included in the differential diagnosis PMF or a hybrid MDS/MPN neoplasm that was unclassifiable. Here, JAK2 is linked to myelodysplastic syndrome.